PLEASANTON, Calif., April 20, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal year 2015 on Thursday, May 7.
The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, May 7, hosted by D. Keith Grossman, President and Chief Executive Officer, and Taylor C. Harris, Vice President and Chief Financial Officer.
The teleconference can be accessed by calling (913) 312-1276, passcode 1716500. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://edge.media-server.com/m/p/jnk4hpxw/lan/en, or http://www.thoratec.com.
A replay of the conference call will be available through Thursday, May 14, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode 1716500.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate II® and HeartMate III™ LVAS (Left Ventricular Assist Systems) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag®, PediMag®/PediVAS®, and HeartMate PHP™ product lines. HeartMate III is an investigational device and is limited by US law to investigational use. HeartMate PHP is currently in development and not approved for sale. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate, and HeartMate II are registered trademarks of Thoratec Corporation and HeartMate III, HeartMate PHP, and IVAD are trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.
SOURCE Thoratec Corporation